This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Phase II Study of Lutetium-177 Labeled Girentuxima...
Clinical trial

Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal Cancer

Read time: 1 mins
Last updated:29th Nov 2013
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest